Aytu Biopharma, Inc SEC filings AYTU
Aytu Biopharma, Inc has 907 filings in SEC EDGAR's recent list, going back to Jan 11, 2007. Its latest annual report, Form 10-K, was filed on Sep 22, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 13, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 22, 2026 (results of operations). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Oct 27, 2026 | — |
| DEF 14A | Proxy statement | Oct 22, 2026 | Dec 10, 2026 |
| 10-K | Annual report | Sep 22, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Sep 22, 2026 | Sep 22, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 4 | Insider transaction | Jul 30, 2026 | Jul 28, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 28, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 28, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 28, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 28, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 28, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 28, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 28, 2026 |
| 8-K |
Current report
Agreement ended
|
Jun 25, 2026 | Jun 23, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Change to shareholder rights
|
Apr 2, 2026 | Mar 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 10-Q | Quarterly report | Feb 3, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 3, 2026 | Feb 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 20, 2026 | Jan 20, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Dec 10, 2025 | Dec 10, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 12, 2025 | — |
| ARS | Annual report to shareholders | Oct 24, 2025 | Jun 30, 2025 |
| DEFA14A | Additional proxy material | Oct 24, 2025 | — |
| DEF 14A | Proxy statement | Oct 24, 2025 | Dec 10, 2025 |
| 5 | Annual insider ownership | Oct 20, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Oct 7, 2025 | Oct 3, 2025 |
| 4 | Insider transaction | Oct 7, 2025 | Oct 3, 2025 |
| 4 | Insider transaction | Oct 7, 2025 | Oct 3, 2025 |
| 4 | Insider transaction | Oct 7, 2025 | Oct 3, 2025 |
| 4 | Insider transaction | Oct 7, 2025 | Oct 3, 2025 |
| 4 | Insider transaction | Oct 7, 2025 | Oct 3, 2025 |
| 4 | Insider transaction | Oct 7, 2025 | Oct 3, 2025 |
| 4 | Insider transaction | Oct 7, 2025 | Oct 3, 2025 |
| S-8 | Employee stock plan registration | Sep 23, 2025 | — |
| 10-K | Annual report | Sep 23, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Sep 23, 2025 | Sep 23, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2025 | — |
| 8-K |
Current report
Agreement ended
|
Aug 7, 2025 | Aug 5, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 26, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jun 26, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jun 26, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 26, 2025 | — |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Jun 23, 2025 | Jun 20, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 17, 2025 | Jun 17, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 13, 2025 | — |
| 4 | Insider transaction | Jun 10, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 6, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 9, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 9, 2025 | Jun 9, 2025 |
| 424B4 | Prospectus | Jun 9, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 6, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
|
Jun 6, 2025 | Jun 5, 2025 |
| S-1MEF | Form s-1mef | Jun 6, 2025 | — |
| EFFECT | Filing | Jun 5, 2025 | — |
| S-1/A | Amended registration statement | Jun 5, 2025 | — |
| CORRESP | Letter to the SEC | Jun 2, 2025 | — |
| CORRESP | Letter to the SEC | Jun 2, 2025 | — |
| S-1 | Registration statement | Jun 2, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 21, 2025 | May 21, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| UPLOAD | Letter from the SEC | May 1, 2025 | — |
| DRS | Filing | Apr 28, 2025 | — |
| 4 | Insider transaction | Mar 31, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | Mar 28, 2025 | Jun 30, 2024 |
| DEFA14A | Additional proxy material | Mar 28, 2025 | — |
| DEF 14A | Proxy statement | Mar 28, 2025 | May 21, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 5, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 28, 2025 |
| 10-Q | Quarterly report | Feb 12, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 12, 2025 | Feb 12, 2025 |
| 4 | Insider transaction | Jan 2, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 4, 2024 | Dec 3, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 13, 2024 | — |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Nov 13, 2024 | Nov 11, 2024 |
| 3 | Initial insider ownership | Nov 13, 2024 | Nov 11, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure, Other events
|
Nov 13, 2024 | Nov 11, 2024 |
| 4 | Insider transaction | Nov 8, 2024 | Nov 6, 2024 |
| 4 | Insider transaction | Nov 8, 2024 | Nov 6, 2024 |
| 4 | Insider transaction | Nov 8, 2024 | Nov 6, 2024 |
| 4 | Insider transaction | Nov 8, 2024 | Nov 6, 2024 |
| 4 | Insider transaction | Nov 8, 2024 | Nov 6, 2024 |
| 4 | Insider transaction | Nov 8, 2024 | Nov 6, 2024 |
| 4/A | Filing | Nov 8, 2024 | Aug 11, 2023 |
| 4 | Insider transaction | Nov 8, 2024 | Nov 6, 2024 |
| EFFECT | Filing | Oct 15, 2024 | — |
| S-3/A | Form s-3/a | Oct 11, 2024 | — |
| CORRESP | Letter to the SEC | Oct 7, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 3, 2024 | — |
| 4 | Insider transaction | Oct 2, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 1, 2024 | Oct 1, 2024 |
| 8-K |
Current report
Results of operations
|
Sep 26, 2024 | Sep 26, 2024 |
| S-3 | Shelf registration | Sep 26, 2024 | — |
| 10-K | Annual report | Sep 26, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 6, 2024 | Aug 6, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 26, 2024 | Jun 26, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Jun 18, 2024 | — |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure, Other events
|
Jun 18, 2024 | Jun 12, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| ARS | Annual report to shareholders | May 10, 2024 | Jun 30, 2023 |
| DEFA14A | Additional proxy material | May 10, 2024 | — |
| DEF 14A | Proxy statement | May 10, 2024 | Jun 26, 2024 |
| 4 | Insider transaction | Apr 2, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 14, 2024 | Feb 14, 2024 |
| 10-Q | Quarterly report | Feb 14, 2024 | Dec 31, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| 4 | Insider transaction | Jan 2, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement
|
Nov 17, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Oct 26, 2023 | Oct 25, 2023 |
| 10-K | Annual report | Oct 12, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 6, 2023 | Oct 3, 2023 |
| 4 | Insider transaction | Oct 3, 2023 | Sep 30, 2023 |
| NT 10-K | Filing | Sep 29, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Sep 27, 2023 | Sep 27, 2023 |
| 4 | Insider transaction | Aug 18, 2023 | Aug 16, 2023 |
| 4 | Insider transaction | Aug 15, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Aug 15, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Aug 15, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Aug 15, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Aug 15, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Aug 15, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Aug 15, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Aug 15, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Aug 15, 2023 | Aug 11, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 15, 2023 | Aug 11, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 31, 2023 | Jul 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 10, 2023 | Jul 10, 2023 |
| 4 | Insider transaction | Jul 6, 2023 | Jun 30, 2023 |
| S-8 | Employee stock plan registration | Jun 23, 2023 | — |
| 3 | Initial insider ownership | Jun 22, 2023 | Jun 13, 2023 |
| 4 | Insider transaction | Jun 20, 2023 | Jun 16, 2023 |
| 4 | Insider transaction | Jun 20, 2023 | Apr 25, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Jun 16, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Jun 16, 2023 | — |
| 4 | Insider transaction | Jun 15, 2023 | Jun 14, 2023 |
| 3 | Initial insider ownership | Jun 15, 2023 | Jun 13, 2023 |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Jun 12, 2023 | Jun 8, 2023 |
| 424B4 | Prospectus | Jun 12, 2023 | — |
| FWP | Free writing prospectus | Jun 9, 2023 | — |
| EFFECT | Filing | Jun 8, 2023 | — |
| CORRESP | Letter to the SEC | Jun 7, 2023 | — |
| CORRESP | Letter to the SEC | Jun 7, 2023 | — |
| FWP | Free writing prospectus | Jun 6, 2023 | — |
| S-1/A | Amended registration statement | Jun 5, 2023 | — |
| SC 13D | Ownership over 5% (active) | May 26, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
May 22, 2023 | May 18, 2023 |
| CT ORDER | Filing | May 16, 2023 | — |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| S-1 | Registration statement | May 1, 2023 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 1, 2023 | Apr 27, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 27, 2023 | Apr 27, 2023 |
| 8-K |
Current report
Other events
|
Apr 19, 2023 | Apr 19, 2023 |
| DEFA14A | Additional proxy material | Apr 7, 2023 | — |
| DEF 14A | Proxy statement | Apr 7, 2023 | May 18, 2023 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 27, 2023 | Mar 24, 2023 |
| 10-Q | Quarterly report | Feb 21, 2023 | Dec 31, 2022 |
| 10-Q/A | Amended quarterly report | Feb 21, 2023 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 21, 2023 | Feb 21, 2023 |
| 8-K |
Current report
Restatement
|
Feb 21, 2023 | Feb 21, 2023 |
| NT 10-Q | Filing | Feb 15, 2023 | Dec 31, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 14, 2023 | Feb 14, 2023 |
| 8-K |
Current report
Officer or director change
|
Feb 14, 2023 | Feb 13, 2023 |
| 4 | Insider transaction | Feb 10, 2023 | Feb 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 25, 2023 | Jan 23, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jan 5, 2023 | Jan 4, 2023 |
| 8-K |
Current report
Other events
|
Dec 30, 2022 | Dec 28, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 27, 2022 | Dec 22, 2022 |
| 4 | Insider transaction | Dec 23, 2022 | Dec 21, 2022 |
| 4 | Insider transaction | Dec 23, 2022 | Dec 21, 2022 |
| 4 | Insider transaction | Dec 23, 2022 | Dec 21, 2022 |
| 4 | Insider transaction | Dec 23, 2022 | Dec 21, 2022 |
| 4 | Insider transaction | Dec 21, 2022 | Dec 19, 2022 |
| 4 | Insider transaction | Dec 21, 2022 | Dec 19, 2022 |
| 8-K |
Current report
Auditor change
|
Dec 13, 2022 | Dec 12, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 30, 2022 | Nov 30, 2022 |
| 4/A | Form 4/a | Nov 28, 2022 | Nov 18, 2022 |
| 4/A | Form 4/a | Nov 28, 2022 | Nov 18, 2022 |
| 8-K |
Current report
Listing notice
|
Nov 22, 2022 | Nov 22, 2022 |
| 4 | Insider transaction | Nov 21, 2022 | Nov 18, 2022 |
| 4 | Insider transaction | Nov 21, 2022 | Nov 18, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 16, 2022 | Nov 16, 2022 |
| 3 | Initial insider ownership | Nov 15, 2022 | Nov 15, 2022 |
| 3 | Initial insider ownership | Nov 15, 2022 | Nov 15, 2022 |
| 3 | Initial insider ownership | Nov 15, 2022 | Nov 15, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AYTU (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Denver, CO
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1385818
- Former names
- AYTU BIOSCIENCE, INC (until Mar 22, 2021); Rosewind CORP (until Jun 8, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.